Search results
Found 15 matches for
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.
Centre for Suicide Research
Depression Economic recession Epidemiology Mental illness Prevention Risk factors Self-harm Suicide